marcus evans europe conferences

20th Annual Strategic Project & Portfolio Management for Pharma

Refocus your strategy with the right prioritisation and project valuation in times of unprecedented disruption

28-29 January 2021
Online, Live+


Why You Should Attend

20th Annual Strategic Project & Portfolio Management for Pharma

With increased impact from the pandemic, pharma and biotech companies are under pressure to deliver results and adapt to new business realities with a fresh approach to PPM. Covid-19 and its aftermath have brought into focus the need to prioritize better and deliver results under increased budget constraints. Project selection and portfolio valuation are crucial tools for PPM managers to understand their competitive advantage, core portfolio values and market forecasts, and to align with their strategic corporate objectives.

This marcus evans unique conference will discuss how you can articulate your priorities better in a COVID-19 environment, and how to overcome increased reporting overload and drive a positive impact in your portfolio strategy. We will explore strategic modeling in times of uncertainty, and how to align R&D and Commercial with an integrated data strategy that takes advantage of AI and machine learning opportunities. By attending this event, you will learn how to do efficient scenario prediction to achieve the right risk-benefit balance in your portfolio, and how in the long run, you can adapt to the new normal with resilient portfolio performance informed by sound-decision making.

Our Live+ digital platform enables you to fully participate in the event remotely. Of course it provides access to live online streams of all session, but much more than that, it ensures you are able to engage with speakers directly allowing you to participate in Q&A, relevant breakout groups as well as event polling and other insights and resources delivered during the event. We realise interacting with other delegates is key to your event experience, so our innovate online solution allows you to set up online meetings with other virtual attendees throughout the event; ensuring you still walk away with those key contacts that can make a tangible difference to you and your business. The platform will continue to host all event content on-demand for you to re-visit and continue to access for up to 6 months post event.

Your content. Your way.


Key Topics

  • Roche discuss the impact of the crisis and how to refocus their PPM strategy
  • LEO Pharma discuss the intedependency between portfolio leadership and management for effective decision-making
  • Ipsen explore project management maturity and performance
  • Bayer reflect on the importance of strategi management and modelling in times of heightened uncertainty
  • Previous Attendees Include

    • Abbott Products Operations Ag
    • Abdi Ibrahim Ilac San. Ve. Tic. A.S.
    • Alkermes Pharma Ireland Limited
    • Almirall Hermal GmbH
    • Astra Zeneca
    • Baxalta
    • Baxter Global Marketing
    • Bayer Pharma AG
    • Biotest AG
    • Boehringer Ingelheim
    • Captario
    • Catenion
    • Cylad Consulting
    • Daiichi-Sankyo Development Ltd.
    • Evaluate
    • F.Hoffman-La Roche AG
    • Fresenius Kabi Deutschland
    • GSK
    • HEXAL AG
    • Janssen Pharmaceutica
    • Janssen Research & Development
    • Jerusalem Pharmaceuticals Company
    • LFB Biotechnologies
    • Medac GmbH
    • Merck Group
    • Mundipharma Research
    • Norgine
    • Novartis
    • Pierre Fabre Pharmaceutical Health Care
    • RB
    • Teva Pharmaceuticals
    • Vifor Pharma


    Why Choose marcus evans?

    marcus evans specialises in the research and development of strategic events for senior business executives. From our international network of 63 offices, marcus evans produces over 1000 event days a year on strategic issues in corporate finance, telecommunications, technology, health, transportation, capital markets, human resources and business improvement.

    Above all, marcus evans provides clients with business information and knowledge which enables them to sustain a valuable competitive advantage and makes a positive contribution to their success.


    Event Sponsors
    Visit website >>
    Visit website >>


    Event Partners


    Practical Insights From

    Dr. Heike Gielen-Haertwig
    Head of Portfolio and Resource Management, Research and Early Development
    Bayer

    Salman Saif
    Director - Head of Strategic Operations & Portfolio Management
    UCB

    Maria Hedwall
    Head of Business Planning & Operations
    AstraZeneca

    Simone Frandsen
    Director, R&D Portfolio and Strategy
    LEO Pharma

    Lesley-Ann Norcross
    Head R&D Strategy and Operations
    Janssen/Johnson&Johnson

    Pratik Patel
    Head, Global Program Management
    F.Hoffmann-La Roche

    Martine Mazzetti
    Head of Project Leadership
    VectivBio

    Click Here For Full Agenda

    Voice of Our Customers
    • “The conference is well organised and speakers are all high quality!” -Programme Coordinator, J&J
    • “High quality speakers, enjoyed the networking” -VP, Debiopharm
    • “I appreciated the conference a lot, having the possibility to compare project management actions of my company with the other companies” -Project Manager R&D, Chiesi
    Latest Conference News & Resources



    Join the Discussion

    Follow on LinkedIn





    Event Contact

    For all enquiries regarding speaking, sponsoring and attending this conference contact:

    Constandinos Vinall


    marcus evans (Europe) Ltd
    PO Box 24797
    1304 Nicosia, Cyprus

    Telephone:
    +357 22849 380
    Fax: +357 22849 394
    Email: constandinosv@marcusevanscy.com